2019 NADDI Pennsylvania Chapter Training – Cancelled

  • 2019 NADDI Pennsylvania Chapter Training
    April 18, 2019
    8:00 am - 5:00 pm

The National Association of Drug Diversion Investigators
Pennsylvania State Chapter


The Pennsylvania Pharmacy Association


The New Pharmacy in America
Livengrin Foundation
4833 Hulmeville Rd.
Bensalem PA

April 18, 2019
9:00 AM – 3:15 PM

April 18, 2019

8:15 AM – 8:45 AM

8:45 AM – 9:00 AM
Welcoming Remarks

9:00 AM – 10:15 AM
“How to Survive a DEA Inspection Series”
UAN: 0159-0000-19-006-L03-P
DEA Compliance, Record Keeping and Pharmacy Due Diligence
Carlos Aquino, Pharma Diversion LLC (Retired Philadelphia Police and DEA Diversion Supervisor)
Learning Objectives: At the completion of this activity, the participant will be able to:
– Discuss the types of federal administrative and civil actions that can be imposed on a pharmacy for failing to maintain complete and accurate records pertaining to the purchase, sale, transfer, dispensing, destruction and theft or loss of controlled substances.
– Identify the responsibilities of DEA through their Diversion personnel to enforce federal laws and DEA regulations by conducting unannounced audits and inspections.
– Discuss DEA record-keeping requirements pertaining to: Biennial Inventory; Executed or Voided DEA Form 222 and Schedules III to V Invoices; Power of Attorney; Theft and Loss; Drug Destruction; and the Storage of Prescriptions.
– Discuss the methods of maintaining DEA required records and the steps to have such records readily retrievable from other records.

10:15 AM – 10:25 AM

10:25 AM – 11:40 AM
Pharmacy Compliance 2019 Update
UAN: 0159-0000-19-005-L03-P
James Schiffer, Esquire –
Mr. Schiffer has been named by American Druggist as one of the nation’s most influential pharmacy leaders for his work concerning the activities of Pharmacy Benefit Management companies and he has received several national awards from pharmacy organizations for his work on behalf of the profession. His experience includes representing clients in audits, investigations and proceedings before the U.S. Food and Drug Administration; Drug Enforcement Administration; and the Centers for Medicare and Medicaid Services.
Learning Objectives: At the completion of this activity, the participant will be able to:
-Explain the role of the Department of Health & Human Services Office of Inspector General (OIG) in the oversight of health care providers in prescription and durable medical supplies.
-Explain what types of behavior in a pharmacy can result in criminal charges based on billing irregularities such as billing for the incorrect product based on the national drug code of the product being billed versus the product
being dispensed.
-Explain and discuss the key issues that pharmacy benefit managers are using for termination of provider status post audit of the pharmacies.
-Explain the reasoning behind what is considered improper and unacceptable off label use for SUBSYS which is generating huge audit recoveries for Medicare Part D prescription claims.
-Explain the responsibilities placed by the United States Department of Health and Human Services Office of Inspector General on the various Pharmacy Benefit Managers, the Medicare Prescription Drug program
administrators and the Medicare Advantage Prescription Drug program administrators in their oversight of pharmacies billing activities for occasions of Fraud, Waste and Abusive billing practices.

11: 40 AM – 12:15 PM
Lunch – Provided by NADDI

12:15 PM – 1:00 PM
Livengrin Addiction with Pharmacy Professionals
UAN: 0159-0000-19-004-L01-P
Sheila Mullen, MSW, LCSW
Sheila Mullen received her Master of Social Work from Temple University’s School of Social work. She is a Licensed Clinical Social Worker with over 19 years of experience working as a clinical therapist. She has experience in treating adults with mental health disorders and addiction in both inpatient and outpatient levels of care. Sheila delivers high quality treatment and assessment services for nurses and other health care professionals.
Learning Objectives: At the completion of this activity, the participant will be able to:
• Identify addiction and the progression of the disease.
• Signs and symptoms of impairment in the workplace.
• Identify ways to access treatment.

1:10 PM – 1:20 PM

1:20 PM – 2:15 PM NPLEx
Krista McCormick – NPLEx
The National Precursor Log Exchange (NPLEx) is a real-time electronic logging and compliance system that tracks sales of over-the-counter (OTC) cold and allergy medications containing pseudoephedrine (PSE), precursors to the illegal drug methamphetamine.

2:15 PM – 3:00 PM RX Patrol
John Gilbride – Purdue Pharma
In an ongoing effort to combat the abuse and diversion of prescription drugs, Purdue Pharma L.P. has conceived, developed and funded an information clearinghouse for data related to pharmacy robberies, burglaries and theft that involves the loss of controlled substances. RxPATROL® (Pattern Analysis Tracking Robberies and Other Losses) is an initiative designed to collect, collate, analyze and disseminate pharmacy theft intelligence to law enforcement throughout the nation.

3:00 PM – 3:15 PM Questions and Answer Session
Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Refund Policy

All registrations are subject to NADDI’s Registration Deadline and Refund Policy.


4833 Hulmeville Rd, Bensalem, Pennsylvania, 19020, United States

National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913

Copyright © 2020 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy

Log in with your credentials


Forgot your details?

Create Account